Are investigator-initiated clinical trials becoming an ‘endangered species’?

Investigator-initiated clinical trials (IITs) are at the core of innovative thinking in health research generating data in real-world settings that influence global policy. Although diminished funding and a reduced workforce pose significant challenges, IITs should be championed as the best model to deliver unbiased, independent health research.